Retatrutide 5mg

Retatrutide is an investigational once-weekly injectable medication developed by Eli Lilly for the treatment of obesity and type 2 diabetes. It functions as a triple hormone receptor agonist, targeting GLP-1, GIP, and glucagon pathways to regulate appetite, enhance insulin secretion, and boost energy expenditure. This multi-receptor approach sets it apart from existing therapies by promoting significant weight loss and improved glycemic control. In clinical trials, Retatrutide demonstrated up to 24.2% mean weight reduction over 48 weeks, making it one of the most promising candidates in metabolic disease treatment.

Ways to purchase:

Rejuv-rx utilizes an Institutional Review Board (IRB) through Cellular Peptide. Rejuv-RX is dedicated to the advancement and improvement of the healthcare industry. We have partnered with an Institutional Review Board (IRB) that assists in our research studies, which are submitted biannually.

Participation in these studies enables us to collect research data to improve and monitor peptide usage and outcomes. We offer our clients the option to purchase peptides utilizing our review board and help track results. To get started, just fill out the form to gain access to the portal. 

If you choose to opt out of our IRB, then understand Product Usage: THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only.

All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused, or mislabeled as a drug, food, or cosmetic.

You can find a video on how to reconstitute your peptides here.

You can find a video on how to inject your peptides here.